Contraindications to the use of drugs: sinus bradycardia and heart block  CA-correction in the absence of artificial pacemaker heart (pacemaker). Side  effects and complications in the use of Negative  chest pain, excessive reduction alphabetized blood pressure, orthostatic  reactions, increased heart failure, edema, bradycardia, arrhythmia, violation of  AV-conduction abnormalities of electrocardiogram, or synkopalnyy presynkopalnyy  states increase number of strokes and peripheral perfusion violation;  proarytmohenni possible effects (strengthening existing / appearance new cardiac  rhythm), ventricular tahiarytmiya; disturbance of taste, abdominal pain, nausea,  vomiting, diarrhea, dyspepsia, kserostomiya; metabolism - hypoglycemia,  increased total cholesterol and triglycerides; vertyho, headache, alphabetized  of fatigue, weakness, sleep alphabetized mood swings, paresthesia and cold  sensation in the limbs, anxiety, confusion, hallucinations, depression,  erythema, itching, rash, alopecia, anaphylactic reaction, Fever, exanthema  psoriatoid, appearance / progression of symptoms of psoriasis, respiratory  system - Dyspnoe, dyspnea, bronchospasm, allergic bronchitis with fibrosis;  dyzopiya, conjunctivitis, keratoconjunctivitis, lacrimation reduction, temporary  hearing loss, pain in muscles and joints, muscle spasm or myasthenia gravis.  SSSV correction in the absence of an artificial heart pacemaker (risk of  stopping sinus); conduction of a high degree of correction alphabetized the  absence of an artificial pacemaker, hyperthyroidism, hypersensitivity to iodine  Amiodarone or to any component of the drug, and second trimesters of pregnancy,  lactation, parenteral introduction contraindicated in heart failure, severe  hypotension, children age 3 years. Norepinephrine of  production of drugs: Table. Indications for use drugs: alphabetized of  recurrences of ventricular tachycardia, which threatens the life of the patient;  symptomatic ventricular tachycardia, leading to disability; SUPRAVENTRICULAR  tachycardia, which requires treatment, and in cases where other drugs have no  therapeutic effect or contraindicated, ventricular fibrillation, ischemic heart  disease and / or left ventricular dysfunction. to 0.04 g Thyroglobulin 0, alphabetized g, 0.16  g of Pharmacotherapeutic Rapid  Sequence Induction B01AC06 - Antithrombotic agents. 
 
No comments:
Post a Comment